TargED Biopharmaceuticals
Signal active
Organization
Contact Information
Overview
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
About
Industries
Biotechnology, Health Care, Pharmaceutical, Biopharma
Founded
2018
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
TargED Biopharmaceuticals headquartered in Europe, operates in the Biotechnology, Health Care, Pharmaceutical, Biopharma sector. The company focuses on Biotechnology and has secured $1.5B in funding across 32 round(s). With a team of 11-50 employees, TargED Biopharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - TargED Biopharmaceuticals, raised $44.2M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
8
Lead Investors
0
Total Funding Amount
$45.8M
Details
2
TargED Biopharmaceuticals has raised a total of $45.8M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Seed | 1.6M | ||
| 2022 | Early Stage Venture | 44.2M |
Investors
TargED Biopharmaceuticals is funded by 16 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Inkef | - | FUNDING ROUND - Inkef | 44.2M |
| TargED Biopharmaceuticals | - | FUNDING ROUND - TargED Biopharmaceuticals | 44.2M |
| First | - | FUNDING ROUND - First | 44.2M |
| TargED Biopharmaceuticals | - | FUNDING ROUND - TargED Biopharmaceuticals | 44.2M |
Recent Activity
There is no recent news or activity for this profile.